INR 279,580 Mn
Total Revenues from Operations
Made in India
Catalyzing
Health Globally
FY26 at a Glance
35,400+
Employee Volunteering Hours
INR 92,405 Mn
EBITDA
48%
Energy from Renewable Sources
2.6 Mn
Patients Reached Through Access
to Healthcare Programs
41%
Reduction in Scope-1 and Scope-2
Emissions in FY26 from Base Year of FY23
73,500
Healthcare Professionals Participated in
Education and Awareness Programs
Global No. 1
ESG Rating in Pharma Sector in S&P Global
R&D
924
Active Patent Applications
444
ANDAs and NDAs filed with U.S. FDA
RANKINGS
3rd
In the U.S. (by Filled Generic Prescriptions)
8th
In Indian Pharma Market
PRODUCTS
30+
Robust Pipeline of Injectables
20+
Robust Pipeline of Respiratory Products
Leadership Messages
Manju Deshbandhu Gupta
Chairperson's Letter
Guided by Purpose
"Science gives us the ability to discover. Purpose gives us the responsibility to serve. Trust is earned by doing both well."
READ MORE
Vinita Gupta | Nilesh Gupta
CEO and MD’s Letter
Living Our Purpose
"Our strategy is simple: invest in differentiated science, execute with discipline and build the capabilities that will define Lupin’s next decade of growth."
READ MORE
Ramesh Swaminathan
CFO's Letter
Purpose-Led Growth
"Strong financial performance is more than an outcome – it is an enabler. Disciplined capital allocation, operational excellence, and prudent risk management give us the confidence to invest consistently in science, manufacturing, and the capabilities that will drive Lupin's long-term growth."
READ MORE
Assurance Statement